# China Summit Capital

> China Summit Capital is a VC fund in Shanghai backing Therapeutics and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 2
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026

China Summit Capital is a VC fund in Shanghai focused on Therapeutics and Biotechnology. China Summit Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 50% |
| Series D | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| IMPACT Therapeutics | IMPACT Therapeutics is dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more thanfour decades of experience in drug development and management. General Manager and Chief Scientific Officer Field are an expert in pharmacology and biology. |  | Series D | Mar 14, 2022 |  |
| IMPACT Therapeutics | IMPACT Therapeutics is dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more thanfour decades of experience in drug development and management. General Manager and Chief Scientific Officer Field are an expert in pharmacology and biology. | $50M | Series C | Dec 01, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 2 deals together
- AJ Asset Management — VC Fund, 1 deal together
- [Bestride](https://shizune.co/investors/profile/bestride-059c) — VC Fund, 1 deal together
- [CCBT Private Equity](https://shizune.co/investors/profile/ccbt-private-equity) — VC Fund, 1 deal together
- [C&D Emerging Investment](https://shizune.co/investors/profile/c-d-emerging-investment) — VC Fund, 1 deal together
- [Dingxin Capital](https://shizune.co/investors/profile/dingxin-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does China Summit Capital invest in?

China Summit Capital invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Series C and Series D stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did China Summit Capital last invest?

The most recent investment recorded for China Summit Capital closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co